KATHY LU: Open Payments
NPI 1366280471 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,769 in 101 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $477 · 2025 $2,769
Food & beverage: $2,680Education: $89
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 31 | $1,142 |
| Janssen Biotech, Inc. | 24 | $359 |
| Enterra Medical, Inc. | 2 | $340 |
| Ardelyx, Inc. | 8 | $289 |
| ABBVIE INC. | 14 | $169 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $158 |
| GENZYME CORPORATION | 3 | $94 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, DUPIXENT, XIFAXAN, CREON, VOQUEZNA, LINZESS.
Industry payments across CA — which companies pay providers there.
